Clinical Trials Browser

Phase 1 × Urinary Bladder Neoplasms × sacituzumab govitecan × Clear all

NCT04794699 2026-04-09

Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

Phase 1 Active not recruiting

GenitourinaryThoracic

Urinary Bladder Neoplasms, Lung Neoplasms